AAA

ACUSENSUS LIMITED.

No trades
See on Supercharts
Market capitalization
‪86.58 M‬AUD
‪55.37 K‬AUD
‪42.00 M‬AUD
‪49.58 M‬
Beta (1Y)
−0.52

About ACUSENSUS LIMITED.

CEO
Alexander Jannink
Headquarters
Melbourne
Founded
2018
ISIN
AU0000259582
FIGI
BBG00YD0P529
Acusensus Ltd. engages in automated camera enforcement technology. It reduces preventable road trauma. The firm offers solutions such as data security and case studies. The company was founded by Ravin Ajit Mirchandani in 2018 and is headquartered in Melbourne, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ACE is 0.700 AUD — it has increased by 2.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ACUSENSUS LIMITED. stocks are traded under the ticker ACE.
ACUSENSUS LIMITED. is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
ACE stock is 5.26% volatile and has beta coefficient of −0.52. Check out the list of the most volatile stocks — is ACUSENSUS LIMITED. there?
Yes, you can track ACUSENSUS LIMITED. financials in yearly and quarterly reports right on TradingView.
ACE stock has risen by 9.37% compared to the previous week, the month change is a 9.37% rise, over the last year ACUSENSUS LIMITED. has showed a 6.06% increase.
ACE net income for the last quarter is ‪−241.43 K‬ AUD, while the quarter before that showed ‪318.18 K‬ AUD of net income which accounts for −175.88% change. Track more ACUSENSUS LIMITED. financial stats to get the full picture.
No, ACE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACUSENSUS LIMITED. stock right from TradingView charts — choose your broker and connect to your account.
ACE reached its all-time high on Feb 13, 2024 with the price of 1.165 AUD, and its all-time low was 0.580 AUD and was reached on Mar 28, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACUSENSUS LIMITED. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACUSENSUS LIMITED. stock shows the sell signal. See more of ACUSENSUS LIMITED. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ACUSENSUS LIMITED. future price: according to them, ACE price has a max estimate of 1.30 AUD and a min estimate of 1.30 AUD. Read a more detailed ACUSENSUS LIMITED. forecast: see what analysts think of ACUSENSUS LIMITED. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACUSENSUS LIMITED. EBITDA is ‪5.68 M‬ AUD, and current EBITDA margin is 13.56%. See more stats in ACUSENSUS LIMITED. financial statements.